期刊文献+

干扰素α-2a的复性DOE研究 被引量:1

Refolding Reasearch of Interferon α-2a via Design of Experiment(DOE) Method
原文传递
导出
摘要 通过DOE(Design of experiment)的方法研究干扰素α-2a(IFNα-2a)蛋白的复性条件,以获得适宜的工业生产条件。以包涵体(Inclusion body,IB)形式在大肠杆菌体内表达的干扰素α-2a蛋白,经过变性、复性后折叠形成天然结构的活性蛋白。通过稀释复性的方法,并对复性液的pH、精氨酸浓度及复性时间进行DOE设计和考察,获得了上述复性参数的工艺范围:复性时间50~60 h,pH(9.9±0.1),精氨酸浓度0.3~0.5 mol/L。复性率为35%~42%,19 min杂质(峰后)小于15%。最终结果表明,精氨酸能有效抑制复性过程中蛋白质的聚集,提高干扰素α-2a折叠效率;从而提高产品收率及该产品的经济效益;pH值的合理选择和复性时间的有效延长可降低19 min杂质含量,进而降低纯化成本。 The renaturation conditions of Interferonα-2 a(IFN α-2 a) was researched via design of experiment(DOE) method to obtain suitable process parameters for industry-scale production. IFN α-2 a was expressed in the form of inclusion bodies in Escherichia coli,which could transform into the folded protein with native structure after denaturation and renaturation. Protein refolding by dilution was mainly described in this article,and the process parameters such as pH value of renaturation solution,concentration of arginine and refolding time were investigated via design of experiment(DOE) method in the form of CCF model. The results were obtained as follows: refolding time varied between 50 and 60 h,pH value varied between 9. 8 and 10. 0,concentration of arginine varied between0. 3 and 0. 5 mol/L,renaturation yield varied between 35 and 42 percent,and impurity content of 19 min was less than 15 percent.The final results indicated that arginine could effectively inhibit the aggregation of proteins during refolding process to improve the refolding efficiency of IFN α-2 a,which would increase the product yield and the economic value of the product. Simultaneously the reasonable selection of pH value and the prolonged refolding time could reduce the impurity content of 19 min,which would lower the cost of the subsequent purification.
出处 《药物生物技术》 CAS 2017年第5期386-391,共6页 Pharmaceutical Biotechnology
关键词 干扰素Α-2A 包涵体 复性 精氨酸 CCF模型 DOE Interferon a-2a, Inclusion body, Renaturation, Arginine, CCF model, DOE
  • 相关文献

参考文献4

二级参考文献64

  • 1吉清,何凤田.包涵体复性的研究进展[J].国外医学(临床生物化学与检验学分册),2004,25(6):516-518. 被引量:16
  • 2万雪,王磊,宁官保.包涵体及其复性研究概况[J].畜牧兽医科技信息,2005,21(2):13-15. 被引量:5
  • 3朱希强,袁勤生.重组人EC-SOD包涵体的稀释复性及重折叠后蛋白的纯化[J].中国生物制品学杂志,2005,18(3):252-255. 被引量:3
  • 4田兴旺,张小华.分子伴侣与蛋白质折叠的研究进展[J].陕西师范大学继续教育学报,2006,23(4):115-117. 被引量:1
  • 5CLARK E D B.Protein refolding for industrial processes[J]. Current Opinion in Biotechnology,2001,12:202-207.
  • 6KOHNO T,CARMICHAEL D F,SOMMER A,et al.Refolding of recombinant proteins[J]. Methods Enzymol,1990,185:187-195.
  • 7VAN KIMMENADE A,BOND M W,SCHUMACHER J H,et al.Expression,renaturation and purification of recombinant human Interleukin 4 from Escherichia coli[J].Eur J Biochem,1988,173:109-114.
  • 8CLARK E D B.Refolding of recombinant proteins[J]. Curr Opin Biotechnol,1998,9(2):157-163.
  • 9MAEDA Y,UEDA T,IMOTO T.Effective renaturation of denatured and reduced immunoglobulin G in vitro without assistance of chaperone[J].Protein Eng,1996,9(1):95-100.
  • 10HWANG H S,CHUNG H S.Preparation of active recombinant cathepsin K expressed in bacteria as inclusion body[J]. Protein Expr Purif,2002,25(3):541-546.

共引文献115

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部